期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胃癌组织^18F—FDG摄取与己糖激酶、乏氧诱导因子和葡萄糖转运蛋白的相关性 被引量：2

原文传递
导出
摘要 胃癌是一种常见的恶性肿瘤，其高转移率及高侵袭性是患者死亡的主要原因。恶性肿瘤细胞由于生长快，需通过改变细胞膜葡萄糖转运、糖酵解及形成肿瘤血管体系等微环境来适应其对缺血缺氧的耐受。细胞Glut增多和细胞内磷酸化酶活性增高等生物学特性，
作者 郭万华 李爱梅 贾支俊 林夏雯 申景涛 郑黎明 陈刚
机构地区 南京大学医学院附属鼓楼医院核医学科 南京大学医学院附属鼓楼医院外科
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2013年第3期226-228,共3页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 国家自然科学基金（81171363） 南京市医学科技发展项目（ZKX09019）
关键词 葡萄糖转运蛋白 胃癌组织 乏氧诱导因子 己糖激酶 ^18F FDG 相关性 恶性肿瘤细胞
分类号 R735.2 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1肖亚景,张祥松,徐卫平,唐安戊,乔穗宪.^(18)F-FDG PET显像在原发性胃癌中的应用[J].中华核医学杂志,2004,24(2):95-97. 被引量：14
  • 2马莉,杨国仁,付政,韩安勤,郑劲松,赵书强,滕学鹏,范廷勇.^18F-FDG PET／CT显像监测胃癌术后复发转移的价值[J].中华核医学杂志,2009,29(3):167-170. 被引量：13
  • 3Wahl R.L, Beanlands USB. Principles and practice of PET andPET/CT. 2nd ed. Philadelphia : Lippincott Williams & Wilkins,2008: 119-121.
  • 4Pore N, Gupta AK, Cemiglia GJ, et al. HIV protease inhibitorsdecrease VEGF/HIF-la expression and angiogenesis in glioblasto-ma cells. Neoplasia, 2006, 8: 889-895.
  • 5张鹏飞,吴继锋,张红,秦蓉,赵文娣,张佐阳.胃癌中HIF-1a、VEGF及Glut1的表达[J].安徽医科大学学报,2010,45(1):86-89. 被引量：22
  • 6蔡莉,张川,李彦生,李大成,邢喜玲,高硕.人脑胶质瘤^18F—FDG摄取与乏氧诱导因子-1α表达及微血管密度的相关性[J].中华核医学杂志,2010,30(1):10-14. 被引量：10
  • 7Qiu MZ, Han B, Luo HY, et al. Expressions of hypoxia-induciblefactor-1 a and hexokinase-Q in gastric adenocarcinoma : the impact onprognosis and correlation to clinicopathologic features. Tumor Biol,2011,32: 159-166.
  • 8Kim BH,Kim U, Kim SS, et al. Relationship between biologicalmarker expression and fluorine-18 fluorodeoxyglucose uptake in in-cidentally detected thyroid cancer. Cancer Biother Radiopharm,2010,25: 309-315.
  • 9Higashi T, Saga T,Nakamoto Y, et al. Relationship between re-tention index in dual-phase 18F-FDG PET, and hexokinase-H andglucose transporter-1 expression in pancreatic cancer. J Nucl Med,2002,43: 173-180.
  • 10Alakus H, Batur M,Schmidt M,et al. Variable 18F-fluorodeoxyglu-cose upt^ce in gastric cancer is associated with different levels ofGlut-1 expression. Nucl Med Commun, 2010,31 : 532-538.

二级参考文献37

  • 1任瑞美,于金明,李文通,宋现让,杨国仁,孙新东,张建东.RNA干扰HIF-1α对人肺腺癌细胞SPCA-1摄取^(18)F-FDG的影响[J].中华核医学杂志,2005,25(3):161-163. 被引量：5
  • 2杨秋蒙,坂东悦郎,川村泰一,米村丰.PET-CT诊断胃癌腹膜转移的临床价值[J].上海交通大学学报（医学版）,2007,27(5):573-576. 被引量：23
  • 3Salaun PY,Grewal RK,Dodamane I,et al.An analysis of the 18F-FDG uptake pattern in the stomach.J Nucl Med,2005,46:48-51.
  • 4Higashi K,Clavo AC,Wahl RL.Does FDG uptake measure proliferative activity of human cancer cells? in vitro comparison with DNA flow cytometry and tritiated thymidine uptake.J Nucl Med,1993,34:414-419.
  • 5Lerut T,Flamen P,Ectora N,et al.Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction:a prospective study based on primary surgery with extensive lymphadenectomy.Ann Surg,2000,232:743-752.
  • 6Chen J,Cheong JH,Yun MJ,et al.Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.Cancer,2005,103:2383-2390.
  • 7De Bree E,Koops W,Kroger R,et al.Peritoneal carcinomatosis from colorectal or appendiceal origin correlation of preoperative CT with intracperative findings and evaluation of interobserver agreement.J Surg Oncol,2004,86:64-73.
  • 8Lim JS,Kim MJ,Yun MJ,et al.Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma.Korean J Radiol,2006,7:249-256.
  • 9Yoshioka T,Yamaguehi K,Kubota K,et al.Evaluation of 18F-FDG PET in patients with advanced,metastatic,or recurrent gastric cancer.J Nucl Med,2003,44:690-699.
  • 10JGCA. Japanese classification of gastric earcinoma-2nd English Edition [ J ]. Gastric Cancer, 1998,1 ( 1 ) :10 - 24.

共引文献55

同被引文献31

  • 1顾爱春,刘建军,孙晓光,施一平,黄钢.NSCLC患者行PET检查的成本效益分析[J].中华核医学杂志,2006,26(2):89-92. 被引量：3
  • 2李少林,王荣福.核医学[M].8版.北京:人民卫生出版社,2013:107-119.
  • 3Xiong QF, Chen Y. Review:deoxyglucose compounds labeled with isotopes different from 18-fuoride: is there a future in clinical prac- tice[J] ? Cancer Biother Radiopharm, 2008, 23(3) : 376-381.
  • 4Yang D, Yukihiro M, Yu DF, et al. Assessment of therapeutic tumor response using 99Tcm-ethylenedicysteine-glucosamine [ J ]. Cancer Biother Radiopharm, 2004, 19(4) : 443-456.
  • 5Yang DJ, Kim CG, Sehechter NR, et al. Imaging with 99Tem ECDG targeted at the multifunetional glucose transport system: feasibility study with rodents[J]. Radiology, 2003, 226(2): 465-473.
  • 6Seheehter NR, Erwin WD, Yang DJ, et al. Radiation dosimetry and biodistribution of 99 -Tcm.ethylene dicysteine-deoxyglueose in pa- tients with non-small-cell lung cancer[ J ]. Eur J Nucl Med Mol Im- aging, 2009, 36(10) : 1583-1591.
  • 7Chen X, Li L, Liu F, et al. Synthesis and biological evaluation of technetium-99m-labeled deoxyglueose derivatives as imaging agents for tumor [ J ]. Bioorg Med Chem Lett, 2006 , 16 ( 21 ) : 5503 -5506.
  • 8Zhang J, Ren J, Lin X, et al. Synthesis and biological evaluation of a novel 99Tcm nitrido radiopharmaceutical with deoxyglucose dithio- carbamate, showing tumor uptake [ J ]. Bioorg Med Chem Lett, 2009. 19(10) : 2752-2754.
  • 9de Barros AL, Cardoso VN, Mota Ld, et al. A novel D-glucose de- rivative radiolabeled with technetium-99m: synthesis, biodistribu- tion studies and scintigraphic images in an experimental model of Ehrlich tumor[J]. Bioorg Med Chem Lett, 2010, 20(8): 2478- 2480.
  • 10Lin X, Jin Z, Ren J, et al. Synthesis and biodistribution of a new 99Tcm-oxo complex with deoxyglueose dithioearhmnate for tumor im- aging[J]. Chem Biol Drug Des, 2012, 79(3): 239-245.

引证文献2

二级引证文献7

中华核医学与分子影像杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部